Telomerase activity in malignant ovarian tumors with deregulation of cell cycle regulatory proteins

Cancer Lett. 1999 Aug 3;142(2):207-17. doi: 10.1016/s0304-3835(99)00170-6.

Abstract

Using a semiquantitative telomeric repeat amplification protocol assay, telomerase-positive frequencies and enzyme levels were measured. Out of 95% of 49 human ovarian tumors, the highest level of telomerase activity was observed in malignant tumors. Furthermore, by immunohistochemical staining of cell cycle regulatory proteins (pRB, p16, cyclin D1, cyclin E and p53) at the G1 checkpoint, we evaluated the relation between each protein alterations and the levels of telomerase activity. We could not demonstrate a clear relation with each molecule except for cyclin E, but suggesting that aberrant accumulation of these proteins was considered as a reason for telomerase deregulation, which may play an essential role in the pathway of telomerase regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cell Cycle Proteins / metabolism*
  • Cyclin D1 / analysis
  • Cyclin E / analysis
  • Cyclin-Dependent Kinase Inhibitor p16 / analysis
  • Female
  • G1 Phase
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Neoplasm Staging
  • Ovarian Neoplasms / enzymology*
  • Ovarian Neoplasms / pathology
  • Polymerase Chain Reaction / methods
  • Telomerase / metabolism*
  • Tumor Suppressor Protein p53 / analysis

Substances

  • Cell Cycle Proteins
  • Cyclin E
  • Cyclin-Dependent Kinase Inhibitor p16
  • Tumor Suppressor Protein p53
  • Cyclin D1
  • Telomerase